SCHEMBL7469698

SCHEMBL7469698

CN(C)c1cccc(C=C2SC(=O)NC2=O)c1-c1cc2c(cc1C(F)(F)F)C(C)(C)CCC2(C)C

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.53
PIM1 P11309 5/20 0.46
PIM2 Q9P1W9 5/20 0.46
TTR P02766 3/20 0.41
CISD1 Q9NZ45 1/20 0.41
PTPN1 P18031 2/20 0.41
ESRRA P11474 3/20 0.40
CYP3A4 P08684 1/20 0.40
NR1H4 Q96RI1 2/20 0.40
IGF1R P08069 1/20 0.40
MYC P01106 1/20 0.39
MAX P61244 1/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
AKR1B1 P15121 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7469695 1.00 GSK3B (0.53) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7468657 0.88 GSK3B (0.59) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7468651 0.88 GSK3B (0.59) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7459436 0.88 TTR (0.50) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7459431 0.88 TTR (0.50) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7464157 0.87 PIM2 (0.48) PIM1PIM2TTRCISD1PTPN1
SCHEMBL7464163 0.87 PIM2 (0.48) PIM1PIM2TTRCISD1PTPN1
SCHEMBL7464545 0.87 GSK3B (0.57) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7464547 0.87 GSK3B (0.57) GSK3BPIM1PIM2TTRCISD1
SCHEMBL7468503 0.86 PIM1 (0.49) PIM1PIM2TTRCISD1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP disclosed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed